Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00893399
Brief Title: Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation

First Submitted : May 5, 2009
First Submitted that Met QC Criteria : May 5, 2009
First Posted : May 6, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : September 28, 2021
Last Update Posted : September 29, 2021